SCHEMBL5128697

SCHEMBL5128697

OC1(C#Cc2cccc(Cl)c2)CCN(Cc2ccccc2Cl)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 2/20 0.45
GAA P10253 2/20 0.45
OPRM1 P35372 1/20 0.45
OPRD1 P41143 1/20 0.45
CYP2A13 Q16696 2/20 0.44
ALDH1A1 P00352 5/20 0.43
KDM4E B2RXH2 4/20 0.43
MAPT P10636 2/20 0.43
RAB9A P51151 2/20 0.43
PLA2G1B P04054 1/20 0.43
ATG4B Q9Y4P1 1/20 0.43
DRD2 P14416 1/20 0.43
DRD4 P21917 1/20 0.43
DRD3 P35462 1/20 0.43
HTT P42858 1/20 0.42
KMT2A Q03164 2/20 0.41
CXCR4 P61073 3/20 0.41
GRM5 P41594 1/20 0.41
MEN1 O00255 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5124116 0.80 GRM5 (0.46) KDM4EDRD2DRD4DRD3KMT2A
SCHEMBL5125408 0.76 CYP2D6 (0.52) GAAOPRM1OPRD1ALDH1A1MAPT
SCHEMBL5127942 0.75 SMO (0.52) OPRM1ALDH1A1KDM4EMAPTRAB9A
SCHEMBL5122918 0.75 GRM5 (0.54) SIGMAR1ALDH1A1MAPTHTTGRM5
SCHEMBL5124137 0.74 GRM5 (0.50) SIGMAR1ALDH1A1MAPTHTTGRM5
SCHEMBL5125859 0.74 GRM5 (0.47) SIGMAR1GAAALDH1A1MAPTRAB9A
SCHEMBL5129146 0.72 GRM5 (0.47) ALDH1A1KMT2AGRM5
SCHEMBL5121798 0.72 MEN1 (0.47) ALDH1A1KDM4EDRD2DRD4DRD3
SCHEMBL5118061 0.72 KMT2A (0.63) SIGMAR1ALDH1A1KDM4EMAPTHTT
SCHEMBL5129376 0.72 GRM5 (0.46) KDM4EMAPTKMT2AGRM5MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080269250-A1 Pyrrolidine and Piperidine Acetylene Derivatives for Use as Mglur5 Antagonists NOVARTIS AG (CH) 2008-10-30 US disclosed
EP-1856107-A1 PYRROLIDINE AND PIPERIDINE ACETYLENE DERIVATIVES FOR USE AS MGLUR5 ANTAGONISTS Novartis AG (CH) 2007-11-21 EP disclosed
WO-2006089700-A1 PYRROLIDINE AND PIPERIDINE ACETYLENE DERIVATIVES FOR USE AS MGLUR5 ANTAGONISTS NOVARTIS AG (CH) 2006-08-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080269250-A1 Pyrrolidine and Piperidine Acetylene Derivatives for Use as Mglur5 Antagonists GRM5, GRIK5, GRM1 SIGMAR1 190/4885GAA 3051/4885OPRM1 43/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.